AI in Oncology Platform
The AI in Oncology platform provides a comprehensive overview of the AI and cancer care intersection. It features profiles, mindmaps, and databases of 140 companies, 475 investors, and 20 hubs, all involved in the AI in Oncology space. The data is organized into seven key categories, including cancer research, cancer diagnostics, genome data analysis, drug development, cancer treatment, cancer screening, and immunotherapy development. This platform offers insights into how AI technologies are shaping the future of cancer diagnosis, treatment, and research.
.png)
Beta Version
AI in Oncology Leaders
The mindmap showcases a diverse community of leaders in AI in Oncology, including computational biologists, oncologists, bioinformaticians, and data scientists, among others. This collaborative network aims to leverage AI to revolutionize cancer research and treatment, leading to more personalized and effective approaches to oncology.
AI in Oncology Analytical Report
Deep Pharma Intelligence’s report, leveraging big data-driven analysis, provides a comprehensive overview of the expanding AI industry, highlighting its value across sectors and regions. This report emphasizes AI’s transformative impact, particularly in oncology, promising cost reductions and improved global health outcomes.
AI in Drug Discovery Platform
The AI in Drug Discovery platform is a digital hub detailing AI’s impact on drug discovery. Explore 800 innovative drug developers, 1,900 niche investors and 50 R&D hubs dedicated to this field. The platform also includes profiles of top 100 leaders in the field of AI in drug discovery. The platform boasts a comprehensive database of key players and investment trends, reviews of significant AI-pharma collaborations from 2021-2023, and showcases AI techniques used by top drug developers.
AI in BioMed Platform
AI in BioMed is a comprehensive platform created to shed light on the developing nexus between artificial intelligence and biotechnology. Access to ground-breaking AI frameworks, powerful investors, business leaders, well-known organizations, and state-of-the-art research facilities are all available through this complex center, which addresses a range of subjects from biomarkers and drug discovery to neurotech and space medicine. AI in BioMed, which personifies the industry's future, acts as the unmistakable entryway to the insights and innovations that help to form and advance the sector.
Explore Solutions
Discover Dashboards Constructor™
Big Data Analytics Dashboard
Deep Pharma Intelligence has engineered an advanced analytical framework capable of defining, analysing, and predicting trends in the AI in Drug Development industry, and the DeepTech technologies powering it.
The Dashboard provides professional users with comparative analytical capabilities, including interactive, searchable and filterable databases of companies, investors and funding rounds, as well as Automated SWOT Analysis and AI-Driven Smart-Matching facilities.
.png)
.png)
.png)
.png)
.png)
Deep Pharma Intelligence – Powered by Deep Knowledge Group
Deep Pharma Intelligence is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.
